Table 3.
Spectrum of Malignancies treated by PRRT with 177Lu-DOTATATE and their relative distribution
| Patients characteristics | Number of Patients |
|---|---|
| 177Lu-DOTATATE PRRT | 1000 |
| 90Y-DOTATATE PRRT | 11 |
| Site of primary disease for 1000 pts | |
| Gastroenteropancreatic NENs (GEP-NENs) | 781 |
| Metastatic NEN with unknown primary (CUP-NEN) | 87 |
| Lung NENs | 30 |
| Mediastinal/thymus NENs | 27 |
| Medullary Thyroid carcinoma (MTC) | 50 |
| Pheochromocytomas and Paraganglioma (PCC/PGL) | 15 |
| Miscellaneous | 10 |